RxDoctor Payments Data

Lois Gonzalez

Psychiatric/Mental Health · Tampa, FLNPI 1164536439

Payments from drug & device makers

$1,997in general payments, 2019–2025

Across 104 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$439
  • Otsuka America Pharmaceutical, Inc.$244
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$215
  • Alkermes, Inc.$147
  • Corium, LLC$138
  • Neurocrine Biosciences, Inc.$110
  • plus $704 from 16 others

What the payments were for

  • Food & beverage$1,94898%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,997 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$14,448
Medicare patients
21
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl40$59,891
Invega SustennaPaliperidone Palmitate11$44,464
RexultiBrexpiprazole14$28,108
Lurasidone Hcl20$17,404
Quetiapine Fumarate ErQuetiapine Fumarate16$6,656
BelsomraSuvorexant14$5,978
Olanzapine16$3,068
Bupropion XlBupropion Hcl132$2,409
Vilazodone Hcl23$2,398
Duloxetine Hcl107$2,067
Aripiprazole46$1,860
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine47$1,416
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$1,381
Prazosin Hcl87$1,366
Quetiapine Fumarate71$1,200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$439$59,89140 claims
Johnson & JohnsonInvega Sustenna$92$44,46411 claims
Otsuka America Pharmaceutical, Inc.Rexulti$244$28,10814 claims
MerckBelsomra$19$5,97814 claims
Almatica Pharma LLCSertraline Hcl$21$37163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →